Israeli Medtech Startup Raises $8 Million Post author:Sam Post published:February 8, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Neurocrine Biosciences Announces Publication Of Positive Results From Kinect 3 Phase III Study Of INGREZZA TM (Valbenazine) For The Treatment Of Tardive Dyskinesia March 20, 2017 BIOTRONIK Release: New ICD Lead With Helical Design Now Launched In Europe April 5, 2017 Boston???s NeoSync Nabs $13 Million in Financing August 10, 2017
Neurocrine Biosciences Announces Publication Of Positive Results From Kinect 3 Phase III Study Of INGREZZA TM (Valbenazine) For The Treatment Of Tardive Dyskinesia March 20, 2017